600211.SS
Latest Trade
48.12CNYChange
-0.32(-0.66%)Volume
3,359,526Today's Range
-
48.2952 Week Range
-
182.07As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 48.44 |
|---|---|
Open | 48.29 |
Volume | 3,359,526 |
3M AVG Volume | 76.68 |
Today's High | 48.29 |
Today's Low | 47.41 |
52 Week High | 182.07 |
52 Week Low | 23.88 |
Shares Out (MIL) | 247.94 |
Market Cap (MIL) | 12,010.11 |
Forward P/E | 26.04 |
Dividend (Yield %) | 1.05 |
Tibet Rhodiola Pharmaceutical's Shareholder Plans To Unload Up To 2% Stake In The Company
Tibet Rhodiola Pharmaceutical's Board Elects Chairman
Tibet Rhodiola Pharmaceutical Plans Share Buyback Worth 70-140 Mln Yuan Within 12 Months
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The Company conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.
Industry
Major Drugs
Executive Leadership
Dabin Chen
Chairman of the Board
Yucheng Zhou
Vice Chairman of the Board
Yuandong Guo
General Manager
Chunyan Yang
Deputy General Manager
Lan Liu
Secretary of the Board
Price To Earnings (TTM) | 28.73 |
|---|---|
Price To Sales (TTM) | 8.75 |
Price To Book (MRQ) | 4.66 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 0.40 |
LT Debt To Equity (MRQ) | 0.40 |
Return on Investment (TTM) | 16.67 |
Return on Equity (TTM) | 14.73 |
Tibet Rhodiola Pharmaceutical Holding Co :
* SAYS BOARD ELECTS CHEN DABIN AS CHAIRMAN Source text in Chinese: https://bit.ly/2WGuuKZ Further company coverage: (Reporting by Hong Kong newsroom)
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.